revance.comRevance Therapeutics - Crunchbase Company Profile & Funding
revance.com Profile
revance.com
Sub Domains:investors.revance.com
Title:Revance Therapeutics - Crunchbase Company Profile & Funding
Description:Contact Email info@revancecom Phone Number 510 742-3400 Revance Therapeutics Inc a biopharmaceutical company engages in developing and commercializing products and treatments in dermatology and aesthetic medicines
Discover revance.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
revance.com Information
Website / Domain: |
revance.com |
HomePage size: | 57.397 KB |
Page Load Time: | 0.335911 Seconds |
Website IP Address: |
104.154.169.201 |
Isp Server: |
Google Inc. |
revance.com Ip Information
Ip Country: |
United States |
City Name: |
Mountain View |
Latitude: |
37.405990600586 |
Longitude: |
-122.07851409912 |
revance.com Keywords accounting
revance.com Httpheader
Server: nginx |
Date: Sat, 22 Aug 2020 05:12:22 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Keep-Alive: timeout=20 |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
Link: https://www.revance.com/wp-json/; rel="https://api.w.org/", https://www.revance.com/; rel=shortlink |
X-Powered-By: WP Engine |
X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
X-Cache: HIT: 2 |
X-Cache-Group: normal |
Content-Encoding: gzip |
revance.com Meta Info
content="width=device-width, initial-scale=1" name="viewport"/ |
content="index, follow" name="robots"/ |
content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1" name="googlebot"/ |
content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1" name="bingbot"/ |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Revance" property="og:title"/ |
content="https://www.revance.com/" property="og:url"/ |
content="Revance" property="og:site_name"/ |
content="https://www.facebook.com/realrevancetherapeutics/" property="article:publisher"/ |
content="2020-08-11T00:06:09+00:00" property="article:modified_time"/ |
content="summary_large_image" name="twitter:card"/ |
content="@revance" name="twitter:creator"/ |
content="@revance" name="twitter:site"/ |
content="#603cba" name="msapplication-TileColor"/ |
content="#ffffff" name="theme-color"/ |
104.154.169.201 Domains
revance.com Similar Website
Domain |
WebSite Title |
revance.com | Revance Therapeutics - Crunchbase Company Profile & Funding |
investors.revance.com | Investor Relations - Revance Therapeutics, Inc. |
blorge.com | Blorge - Crunchbase Company Profile & Funding |
mx.jobspotting.com | Jobspotting - Crunchbase Company Profile & Funding |
filosofiaparatodos.bligoo.com | Bligoo - Crunchbase Company Profile & Funding |
gotodaily.com | GotoDaily - Crunchbase Company Profile & Funding |
washjrnl.exposuremanager.com | ExposureManager - Crunchbase Company Profile & Funding |
dropkaffe.com | DropKaffe - Crunchbase Company Profile & Funding |
olympicphotogroup.exposuremanager.com | ExposureManager - Crunchbase Company Profile & Funding |
davebreen.exposuremanager.com | ExposureManager - Crunchbase Company Profile & Funding |
leelocke.exposuremanager.com | ExposureManager - Crunchbase Company Profile & Funding |
rskinner.exposuremanager.com | ExposureManager - Crunchbase Company Profile & Funding |
atossagenetics.com | Atossa Therapeutics - A Clinical-Stage Biopharmaceutical Company |
acorda.com | Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments |
jphotograph.exposuremanager.com | ExposureManager Crunchbase |
revance.com Traffic Sources Chart
revance.com Alexa Rank History Chart
revance.com Html To Plain Text
Skip to Content Back Contact Menu Aesthetics Back Aesthetics Overview RHA® HintMD Neuromodulator Neuromodulator Uses Clinical Highlights Therapeutics Back Therapeutics Overview Our Science Muscle Movement Disorders Pain Disorders Clinical Highlights Investors Back Investors LATEST NEWS Our Latest July 29, 2020 Dustin S. Sjuts of Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry All News Investor Relations Press Releases Events & Webcasts Corporate Governance Financials & Filings Stock Information Analyst Coverage Investor FAQ Company Back Company OUR LATEST Our Latest July 29, 2020 Dustin S. Sjuts of Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry Our Latest Overview About Leadership Team Board of Directors Partnerships Contact Corporate Social Responsibility News Careers Back Careers Overview Career Opportunities Culture Benefits & Perks facebook instagram twitter linkedin 7555 Gateway Boulevard Newark, California 94560 +1 (510) 742-3400 Contact © Copyright 2020 All Rights Reserved Terms of Use Privacy Policy Daring to Make a Difference Join Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices is a biotechnology company focused on innovative aesthetic and therapeutic offerings Aesthetics We are building a powerful premium aesthetics category focused on differentiated products, improved outcomes, and an elevated experience for healthcare professionals and patients. Learn More Therapeutics We are evaluating therapeutic indications in muscle movement and pain disorders to meaningfully transform patient experiences. Learn More Facts, Figures & Trends Neuromodulators are the most performed minimally invasive cosmetic procedures, followed by dermal fillers 1 Explore Aesthetics There are 12 Approved Therapeutic Indications for Botulinum Toxin Type A in the U.S. and hundreds of potential indications 2 Explore Therapeutics All News Jul 2020 Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices Read More Our Latest May 2020 announces addition of fintech platform for aesthetic practices with acquisition of HintMD Read More Investor Info Stock Quote $25.29 EXCHANGE NYSE (US DOLLAR) 0.17 VOLUME 328,404 Price could be delayed by up to 15 mins References The American Society of Plastic Surgeons. 2018 Plastic Surgery Statistic Report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf . Accessed July 2019 Time Magazine, January 16, 2017, How BOTOX Became the Drug That’s Treating Everything. Available at: https://time.com/4623409/botox-drug-treating-everything/ . Accessed April 2020 Keep up with Subscribe 7555 Gateway Boulevard Newark, California 94560 +1 (510) 742-3400 facebook instagram twitter linkedin Aesthetics Overview RHA® HintMD Neuromodulator Neuromodulator Uses Clinical Highlights Therapeutics Overview Our Science Muscle Movement Disorders Pain Disorders Clinical Highlights Investors Investor Relations Press Releases Events & Webcasts Corporate Governance Financials & Filings Stock Information Analyst Coverage Investor FAQ Company Overview About Leadership Team Board of Directors Partnerships Contact Corporate Social Responsibility News All News In the News Our Latest Careers Overview Career Opportunities Culture Benefits & Perks © Copyright 2020 All Rights Reserved Terms of Use Privacy Policy Corporate Social Media Community Guidelines Back to top By selecting "I accept," I authorize , or any contracted third parties acting on its behalf, to install cookies on my browser. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. Privacy Policy ACCEPT Privacy & Cookies Policy Close Non Necessary non-necessary This is an non-necessary category. Save & Accept...
revance.com Whois
"domain_name": "REVANCE.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": "2019-12-06 12:49:06",
"creation_date": "2000-07-05 18:33:11",
"expiration_date": "2021-07-05 18:33:11",
"name_servers": [
"NS1-03.AZURE-DNS.COM",
"NS2-03.AZURE-DNS.NET",
"NS3-03.AZURE-DNS.ORG",
"NS4-03.AZURE-DNS.INFO"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": null,
"address": null,
"city": null,
"state": null,
"zipcode": null,
"country": null